Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Newly Diagnosed, Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Damon R Reed
Pediatric Early Phase Clinical Trial Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
Suspended - Children'S Hospital Los Angeles
Los Angeles, California, United States
Suspended - Children'S Hospital of Orange County
Orange, California, United States
Suspended - Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
Suspended - Ucsf Medical Center-Mission Bay
San Francisco, California, United States
Suspended - Children'S Hospital Colorado
Aurora, Colorado, United States
Suspended - Children'S National Medical Center
Washington D.C., District of Columbia, United States
Suspended - Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
Suspended - Children'S Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, United States
Suspended - Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
Suspended - Riley Hospital for Children
Indianapolis, Indiana, United States
Suspended - Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
Suspended - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Suspended - C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
Suspended - University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
Suspended - Children'S Mercy Hospitals and Clinics
Kansas City, Missouri, United States
Suspended - Washington University School of Medicine
St Louis, Missouri, United States
Shalini ShenoyRecruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Suspended - Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
Suspended - Duke University Medical Center
Durham, North Carolina, United States
Jessica M. SunRecruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Suspended - Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Suspended - Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
Suspended - Saint Jude Children'S Research Hospital
Memphis, Tennessee, United States
Jessica GartrellRecruiting - Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
Active, not recruiting - Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
Suspended - Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
Active, not recruiting - Primary Children'S Hospital
Salt Lake City, Utah, United States
Suspended
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Mar 2021
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2027
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 55
- Registry id
- NCT04616560
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.